Updated 10 August 2026. Regulatory status current as of this date.
Most approved peptide medicines are legal when prescribed appropriately. But wellness and lifestyle peptides such as BPC-157, TB-500 and MOTS-c remain unapproved and unproven; the FDA’s July 2026 advisory vote did not make them approved or immediately legal to compound. UK rules depend partly…
CJC-1295 has one of the strongest published human clinical records of any wellness-market peptide, a Phase 2 trial that was discontinued after a participant death, and a December 2024 FDA advisory committee vote against allowing it into the regulated compounding system. The gap between the science and the regulatory verdict is where its current safety…



